The Defence Your Skin Cannot Build From Supplements Alone.
IV Concentrations. Clinical Activity. Systemic Effect. — Antioxidant IV Infusion at Ministry of Skin delivers a precisely formulated combination of high-dose vitamins, antioxidants, and coenzymes directly into the bloodstream — achieving tissue concentrations that the gastrointestinal limitations of oral supplementation make unavailable regardless of the dose or quality of what is taken orally. For patients who want systemic antioxidant protection, collagen synthesis support, and the cellular energy improvement that intravenous delivery provides, this is the most direct and most effective route available.
Overview
The case for antioxidant supplementation in anti-ageing is well-established at the cellular level: oxidative stress — the accumulation of reactive oxygen species generated by UV exposure, pollution, stress, and metabolic activity — is one of the primary drivers of accelerated skin ageing, collagen degradation, and the pigmentary changes that accumulate over years of environmental exposure. Neutralising these reactive oxygen species before they damage cellular proteins, lipid membranes, and DNA requires an adequate supply of antioxidant molecules — Vitamin C, glutathione, alpha lipoic acid, coenzymes — in the tissue where the oxidative damage is occurring.
The problem with oral antioxidant supplementation is pharmacokinetic. Vitamin C absorbed through the gastrointestinal tract is tightly regulated — plasma concentrations plateau at approximately 200–400 μmol/L regardless of the dose ingested, because intestinal absorption is saturating and excess is renally excreted before blood levels can rise further. Intravenous Vitamin C at the doses used in clinical infusion achieves plasma concentrations 30–50 times higher — concentrations at which the molecule's antioxidant, collagen-stimulating, and immunological activities operate at a clinical rather than physiological maintenance level. This is not a difference of degree. It is a difference of mechanism: what high-dose IV Vitamin C does in tissue is qualitatively different from what oral supplementation achieves.
At Ministry of Skin, the Antioxidant IV Infusion is administered as part of a medically supervised programme — prescribed by a dermatologist following a pre-infusion health assessment, delivered in a clinical environment, and monitored for both response and tolerability. All patients complete a pre-infusion assessment before their first session, including G6PD screening for patients receiving high-dose Vitamin C.
What the Infusion Contains
High-dose Vitamin C — the primary active component. At intravenous concentrations, Vitamin C acts as a powerful antioxidant, neutralising reactive oxygen species in the tissue directly. It is also the essential cofactor for prolyl and lysyl hydroxylase — the enzymes responsible for post-translational collagen modification — making adequate Vitamin C a biological requirement for the production of structurally sound, functional collagen. At IV concentrations, it provides the maximum possible substrate for collagen synthesis throughout all collagen-producing tissue simultaneously. B-Complex Vitamins — including B1, B2, B3, B5, B6, and B12 — support the mitochondrial energy metabolism that underlies all cellular repair and regeneration.
Glutathione — the body's most abundant intracellular antioxidant — contributes to the systemic antioxidant loading alongside its specific melanin-modulatory effect on tyrosinase activity. Combined with high-dose Vitamin C, glutathione provides complementary antioxidant protection through its role in the cellular glutathione peroxidase system. Alpha Lipoic Acid — a mitochondrial antioxidant that regenerates both Vitamin C and Vitamin E from their oxidised forms, extending the antioxidant capacity of both molecules beyond the duration of their own direct activity.
Clinical Applications & Programme
The Clinical Applications in Anti-Ageing
Systemic collagen protection — the primary anti-ageing application. The free radicals generated by UV exposure, environmental pollution, and metabolic activity degrade collagen through direct oxidative damage and through the activation of matrix metalloproteinases — the enzymes responsible for collagen breakdown. High-dose intravenous antioxidants neutralise these free radicals throughout all tissue simultaneously, reducing the rate of oxidative collagen degradation and providing the molecular substrate — specifically Vitamin C — for the synthesis of replacement collagen.
Pre- and post-procedure support — the infusion is used at Ministry of Skin around laser resurfacing, MNRF, and other procedures that involve controlled tissue trauma and collagen remodelling. The high-dose Vitamin C and B-complex support the healing metabolism, provide the collagen synthesis substrate at the moment the procedure is stimulating maximum fibroblast activity, and protect the newly formed collagen from oxidative damage during the remodelling period. Patients who incorporate IV infusion around their procedure programme consistently show faster, higher-quality healing responses.
Immune support and systemic vitality — the B-complex and glutathione components support immune cell function and the systemic cellular energy that underlies the general quality of health and vitality that is reflected in the skin. For patients who are depleted, recovering from illness, or under sustained high-demand, the improvement in systemic cellular energy following a course of infusions is reflected in the skin alongside the improvement in energy and immune resilience.
The Programme at Ministry of Skin
The Antioxidant IV Infusion is administered through an intravenous cannula in a private, comfortable clinical room. The infusion takes 30–45 minutes. A course of 4–6 weekly or fortnightly sessions establishes therapeutic tissue antioxidant levels; monthly maintenance sessions sustain them.
Clients
Testimonials
Frequently Asked Questions
How does IV delivery differ from high-dose oral supplements?
IV Vitamin C achieves plasma concentrations 30–50 times higher than the maximum possible with oral supplementation — because oral absorption is strictly regulated and excess is renally excreted before blood levels can rise. At these higher plasma concentrations, Vitamin C's antioxidant, collagen-stimulating, and immunological activities operate at a level that oral supplementation cannot achieve regardless of the dose taken.
Is the infusion safe?
Yes — when administered following appropriate pre-infusion screening by a qualified medical professional. The most important pre-infusion consideration is G6PD deficiency — a genetic enzyme deficiency that contraindicates high-dose IV Vitamin C — which is screened for before the first infusion. All infusions use sterile single-use consumables in a supervised clinical environment.
Can the infusion be combined with in-clinic skin treatments?
Yes — and at Ministry of Skin, infusion sessions are frequently timed around laser, MNRF, or other procedure appointments to provide systemic antioxidant and collagen-synthesis substrate support around the treatment. The combination of in-clinic structural treatment and systemic biological support consistently produces better outcomes than either approach alone.
How many sessions before I notice a difference?
Most patients begin to notice improved skin luminosity, improved energy levels, and enhanced wellbeing within 3–4 sessions of a weekly course. More significant and consistent improvement in systemic antioxidant protection and skin quality develops over the full 4–6 session initial course. Monthly maintenance sustains the improvement.
Who benefits most from Antioxidant IV Infusion?
Patients with significant UV exposure history who want to protect and preserve remaining collagen. Patients undergoing active skin procedures who want to optimise healing and collagen remodelling. Patients who are systemically depleted — from illness, sustained stress, or high metabolic demand — and whose skin reflects that depletion. And patients who want the most comprehensive anti-ageing programme that addresses both the in-clinic structural and quality improvements and the systemic biological environment in which those improvements occur.
